These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 7940841
21. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients. Dibo-Cohen JM, Conort O, Conti F, Bernard D, Hazebroucq G, Calmus Y. Transplant Proc; 1998 Aug; 30(5):1857. PubMed ID: 9723309 [No Abstract] [Full Text] [Related]
22. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases]. Cherqui D, Duvoux C, Charlotte F, Humeres R, Lauzet JY, Métreau JM, Salvat A, Rotman N, Julien M, Fagniez PL. Gastroenterol Clin Biol; 1994 Aug; 18(2):115-22. PubMed ID: 8013792 [Abstract] [Full Text] [Related]
23. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients. Tchervenkov JI, Tector AJ, Cantarovich M, Tahta SA, Asfar A, Naimi J, Elias N, Barkun J. Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214 [No Abstract] [Full Text] [Related]
24. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients. Hricik DE, Seliga RM, Fleming-Brooks S, Bartucci MR, Schulak JA. Clin Transplant; 1995 Oct; 9(5):419-23. PubMed ID: 8541637 [Abstract] [Full Text] [Related]
25. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen. Nohria A, Ehtisham J, Ramahi TM. J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855 [Abstract] [Full Text] [Related]
26. Long-term effect of cyclosporine on renal function in children after liver transplantation. Bilik R, Superina RA, Hu X. Transplant Proc; 1993 Aug; 25(4):2578-9. PubMed ID: 8356677 [No Abstract] [Full Text] [Related]
27. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study. Masri MA, Shakuntala V, Dhawan IK, Zahir M, Shanwaz M, Hayes K, Pingle A. Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889 [No Abstract] [Full Text] [Related]
28. Immunosuppression in live-related donor renal transplantation. Iman A, Rao M, Juneja R, Jacob CK. Natl Med J India; 2001 Jun; 14(2):75-80. PubMed ID: 11396322 [Abstract] [Full Text] [Related]
29. Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Jazzar A, Fagiuoli S, Sisson S, Zuhdi N, Cooper DK. Transplant Proc; 1994 Oct; 26(5):2749. PubMed ID: 7940864 [No Abstract] [Full Text] [Related]
30. Effects of prostaglandin E1 therapy on cyclosporine A and creatinine levels after orthotopic heart transplantation. Iberer F, Vujicic R, Rödl S, Wasler A, Sabin K, Koshsorur A, Allmayer T, Auer T, Petutschnigg B, Tscheliessnigg KH. Transplant Proc; 1994 Dec; 26(6):3246-8. PubMed ID: 7998131 [No Abstract] [Full Text] [Related]
31. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation. Heroux AL, LeBlanc MH, Beaudoin D, Simard S, Coulombe DA, Gleeton O, Lemieux MD, Doyle DP. Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219 [No Abstract] [Full Text] [Related]
33. Cadaveric renal transplantation with cyclosporine monotherapy. Aikawa A, Sells RA, Bakran A, Tewari A. Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623 [No Abstract] [Full Text] [Related]
34. Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy. Odocha O, Kelly B, Trimble S, Murigande C, Toussaint RM, Callender CO. Transplant Proc; 1996 Apr; 28(2):907-9. PubMed ID: 8623456 [No Abstract] [Full Text] [Related]
35. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation. Falkiewicz K, Kamińska D, Nahaczewska W, Boratyńska M, Owczarek H, Klinger M, Woźniak M, Patrzałek D, Szyber P. Transplant Proc; 2006 Apr; 38(1):119-22. PubMed ID: 16504680 [Abstract] [Full Text] [Related]
36. Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients. Bilbao I, Parrilla P, Rimola A, Figueras J, Fabrega E, Gomez M, De Vicente E, Margarit C. Transplant Proc; 1998 Aug; 30(5):1833-7. PubMed ID: 9723300 [No Abstract] [Full Text] [Related]
37. Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients. Baruch Y, Assy N, Kramsky R, Enat R. Transplant Proc; 1998 Aug; 30(5):1852-3. PubMed ID: 9723306 [No Abstract] [Full Text] [Related]
38. Improved outcome after 'bottom-up' immunosuppression in liver transplant recipients with preoperative renal impairment. Schnitzbauer AA, Doenecke A, Sothmann JL, Loss M, Farkas SA, Hartl J, Tsui TY, Baier L, Kirchner G, Obed A, Bein T, Geissler EK, Scherer MN, Schlitt HJ. Eur Surg Res; 2010 Aug; 45(3-4):356-67. PubMed ID: 21088426 [Abstract] [Full Text] [Related]
39. Clinical outcome after cyclosporine dose reduction based on C2 levels in long-term liver transplant patients. Tha-In T, Hesselink DA, Tilanus HW, Elshove L, Wilschut AL, Hansen BE, van Gelder T, Metselaar HJ. Clin Transplant; 2005 Aug; 19(4):537-42. PubMed ID: 16008602 [Abstract] [Full Text] [Related]
40. Effects of nicardipine on blood cyclosporine levels in renal transplant patients. Guan D, Wang R, Lu J, Wang M, Xu C. Transplant Proc; 1996 Jun; 28(3):1311-2. PubMed ID: 8658673 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]